Company Quick10K Filing
Remsleep Holdings
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-05-18
10-K 2019-12-31 Filed 2020-04-10
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-15
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-17
10-Q 2018-03-31 Filed 2018-06-28
10-K 2017-12-31 Filed 2018-06-28
10-Q 2017-09-30 Filed 2018-02-06
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-18
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2017-02-23
10-Q 2016-06-30 Filed 2017-02-22
10-Q 2016-03-31 Filed 2017-02-22
10-K 2015-12-31 Filed 2017-02-15
10-Q 2015-09-30 Filed 2017-01-04
10-Q 2015-06-30 Filed 2016-12-30
10-Q 2015-03-31 Filed 2016-12-30
10-K 2014-12-31 Filed 2016-04-14
10-Q 2014-06-30 Filed 2015-03-02
10-Q 2014-06-30 Filed 2015-03-02
10-Q 2014-03-31 Filed 2015-02-25
10-K 2013-12-31 Filed 2015-02-04
10-Q 2013-09-30 Filed 2013-12-03
10-Q 2013-06-30 Filed 2013-08-26
10-Q 2013-03-31 Filed 2013-06-27
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-22
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-18
10-K 2009-12-31 Filed 2010-04-07
8-K 2020-01-30
8-K 2020-01-27
8-K 2018-07-26
8-K 2018-01-29

Remsleep Holdings Financials

RMSL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Alpine 4 Technologies (ALPP) 2,373 25% 2.8 -4% 26,273 37,478 20,690 5,148 -1,162 2,666 7,436
Quantrx Biomedical (QTXB) 2,361 -13.3 -81% 384 2,200 0 0 -309 -166 2,206
Evolutionary Genomics (FNAM) 2,353 0% -4.2 -12% 4,432 975 116 0 -538 -508 2,135
Mount Tam Biotechnologies (MNTM) 2,228 -1.8 -6,794% 20 2,877 0 0 -1,333 -1,248 2,219
Electronic Systems Technology (ELST) 2,228 54% -46.8 -2% 1,982 93 1,141 613 -49 -43 2,028
BioSolar (BSRC) 2,213 2.1 1,165% 145 14,186 0 0 1,685 2,403 4,975
Innerscope Hearing Technologies (INND) 2,206 57% -0.7 -118% 4,220 8,205 657 372 -4,980 -4,663 3,150
Remsleep Holdings (RMSL) 2,194 -0.8 -1,529% 197 1,096 0 0 -3,016 -2,978 2,343
iSIGN Solutions (ISGN) 2,189 0% -2.8 -549% 148 5,210 639 0 -812 -762 2,152
OLB Group (OLBG) 2,187 0% -11,960.1 -11% 11,509 14,314 7,650 0 -1,282 -1 11,661
Prestige Capital (PGEC) 2,166 -109.1 -15,390% 0 199 0 0 -20 -20 2,166
Egalet (EGLT) 2,150 0% -3.1 -17% 239,048 190,645 60,230 0 -40,416 -30,381 93,425
Enviro Technologies (EVTN) 2,147 30% -3.1 -38% 1,895 2,998 156 46 -715 -701 2,151
Mountain High Acquisitions (MYHI) 2,122 100% -0.4 -1,517% 323 285 79 79 -4,904 -4,818 2,026
Dougherty's Pharmacy (MYDP) 2,079 33% -95.8 -40% 8,462 10,364 27,384 9,125 -3,358 -41 3,927
Cloudweb (CLOW) 2,079 -41.9 0 312 0 0 -49 -52 2,188
Nulife Sciences (NULF) 2,078 1% -0.6 -5,624% 62 1,925 11 0 -3,506 -3,465 2,049
Innovative Designs (IVDN) 2,051 29% -3.5 -38% 1,598 755 271 79 -610 -600 2,101
Sangui Biotech International (SGBI) 2,015 100% -7.2 -591% 46 -8 77 77 -271 -276 1,994
Delcath Systems (DCTH) 2,011 0.7 -113% 18,895 37,720 0 622 -21,371 -19,451 -13,504

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash46641901019010000000002521411744182102
Accounts Receivable
Inventory
PP&E141414151413131312151515223238626374
Assets57121025010-020191919191818132091841182448557113273197
Accounts Payable141155142142211214222226226226226226226226226226229240243243244240249241241
Long-Term Debt182311250
Liabilities460151047159211,1201,3123,4663,8373,4103634014013143373403403313703926814894836336371,2341,3451,096
Stockholders' Equity1112-5-79-714-921-1,120-1,312-3,466-3,837-3,410-343-382-381-295-318-321-322-319-351-383-498-371-239-548-580-1,121-1,072-899
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000
Cost of Revenue00000000
Gross Profit00000000
R&D
SG&A71164-63267384598161844
Tax00000000000000000000000000
Net Income-18,923-17-55-1,244-206-370-198-2,138-861428-34-39-0-57-26-3-0-415-389-48-453-162-308-349-592-2,347-77
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-64-1750-54-42-784-71-34-380-56-26-0-19-23-27-25-42-56-52
Cash Investing-100030-3300-7-19-24-2-27
Cash Financing2415-232042784403605823601939201978-88494196-1